Search results
‘Memoir of a Snail’ Wins Annecy Film Festival
The Hollywood Reporter via Yahoo News· 7 days agoAdam Elliot’s oddball Aussie feature Memoir of a Snail has won the Cristal award for best feature film at the 2024 Annecy Film Festival, the world’s...
Oldest wine ever discovered contains a horrifying secret ingredient: study
NY Post via Yahoo News· 3 days agoAmong other artifacts, this subterranean treasure trove contained a funerary urn with “cremated bone...
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
Zacks via Yahoo Finance· 2 days agoLet's take a look at some of our top-ranked mutual funds with the lowest fees. Janus Henderson...
From Slip-On Flats to Loafers, Fendi’s Spring 2025 Men’s Shoe Offering Goes Preppy
Footwear News via Yahoo News· 6 days agoAlong with the squirrel, the Italian luxury brand’s accessories and men’s artistic director was...
Veteran concerns are top of mind for Rep. Chavez-DeRemer during one day visit
The Bulletin· 4 days agoFrom mental health to timely treatment, veterans issues were top of mind for U.S. Rep. Lori...
Oracle (NYSE:ORCL) Given New $165.00 Price Target at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 5 days agoOracle (NYSE:ORCL – Free Report) had its price target upped by Deutsche Bank Aktiengesellschaft from $150.00 to $165.00 in a report published on Monday, Benzinga reports. The firm currently ...
Oracle (NYSE:ORCL) Trading Up 1.7% After Analyst Upgrade
ETF DAILY NEWS· 4 days agoOracle Co. (NYSE:ORCL – Get Free Report)’s stock price traded up 1.7% during trading on Tuesday after Argus raised their price target on the stock from $145.00 to $159.00. Citigroup cut their ...
Masonite International (NYSE:DOOR) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com started coverage on shares of Masonite International (NYSE:DOOR – Free Report) in a research note published on Wednesday. The brokerage issued a hold rating on the stock. Other ...
Topical Treatment Effective for Young Kids Up to 52 Weeks
Medscape· 6 days agoNo treatment-related interruptions, discontinuations, or serious adverse events were observed with...
Upadacitinib User Survey Confirms Eczema Clinical Data
Medscape· 3 days agoIn a survey of adults with moderate to severe AD participating in a patient support program for upadacitinib in the United States, 86.8% reported that their itch was "very much" or "much" improved ...
